Dyne Therapeutics Inc.
DYN | NASDAQ
$17.39
+$0.27 (+1.58%)
Sep 22, 2026, 11:39 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 521K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | -521K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -181.66M | -125.28M | -116.13M | -113.89M | -115.79M | -122.37M | -97.11M | -105.66M | -71.96M | -69.16M | -67.69M | -62.27M | -66.74M | -45.46M | -40.15M | -42.28M | -52.76M | -35.78M | -51.96M | -42.77M | -30.17M | -25.13M |
Interest Income | n/a | 8.76M | 7.66M | 8.48M | 6.63M | 7.1M | 7.59M | 9.28M | 7.05M | 3M | 1.75M | 2.19M | 2.21M | 1.49M | 1.34M | 903K | 441K | 230K | 182K | 184K | 210K | 166K |
Pretax Income | -178.56M | -120.85M | -111.96M | -108.04M | -110.86M | -115.36M | -89.54M | -97.13M | -65.1M | -65.65M | -66.64M | -60.21M | -64.9M | -44.19M | -38.83M | -41.39M | -52.3M | -35.58M | -51.79M | -42.58M | -29.96M | -24.97M |
Net Income | -178.56M | -120.85M | -111.96M | -108.04M | -110.86M | -115.36M | -89.54M | -97.13M | -65.1M | -65.65M | -66.64M | -60.21M | -64.9M | -44.19M | -38.83M | -41.39M | -52.3M | -35.58M | -51.79M | -42.58M | -29.96M | -24.97M |
Selling & General & Admin | 29.49M | 24.39M | 20.7M | 16.67M | 16.56M | 15.93M | 15.3M | 12.86M | 9.7M | 24.62M | 8.84M | 7.02M | 7.61M | 7.93M | 6.95M | 7.61M | 6.09M | 7.55M | 9.66M | 6.26M | 6.29M | 6.51M |
Research & Development | 152.17M | 100.89M | 95.43M | 97.22M | 99.24M | 106.45M | 81.81M | 92.8M | 62.26M | 44.54M | 58.84M | 55.25M | 59.13M | 37.54M | 33.19M | 34.67M | 46.66M | 28.24M | 42.3M | 36.51M | 23.87M | 18.63M |
Other Expenses | n/a | n/a | -521K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 181.66M | 125.28M | 115.61M | 113.89M | 115.79M | 122.37M | 97.11M | 105.66M | 71.96M | 69.16M | 67.69M | 62.27M | 66.74M | 45.46M | 40.15M | 42.28M | 52.76M | 35.78M | 51.96M | 42.77M | 30.17M | 25.13M |
Interest Expense | n/a | 4.2M | 3.19M | 2.9M | 94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 181.66M | 125.28M | 116.13M | 113.89M | 115.79M | 122.37M | 97.11M | 105.66M | 71.96M | 69.16M | 67.69M | 62.27M | 66.74M | 45.46M | 40.15M | 42.28M | 52.76M | 35.78M | 51.96M | 42.77M | 30.17M | 25.13M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 165.45M | 165.04M | 128.44M | 141.81M | 113.87M | 109.91M | 101.98M | 100.88M | 92.51M | 81.04M | 61.39M | 61.11M | 59.84M | 56.33M | 52.47M | 51.8M | 51.68M | 51.6M | 51.54M | 51.32M | 51.22M | 49.47M |
Shares Outstanding (Diluted) | 165.45M | 165.04M | 128.44M | 141.81M | 113.87M | 109.91M | 101.98M | 100.88M | 92.51M | 81.04M | 61.39M | 61.11M | 59.84M | 56.33M | 52.47M | 51.8M | 51.68M | 51.6M | 51.54M | 51.32M | 51.22M | 49.47M |
EPS (Basic) | -1.08 | -0.73 | -0.76 | -0.76 | -0.97 | -1.05 | -0.88 | -0.96 | -0.70 | -0.81 | -1.09 | -0.99 | -1.08 | -0.75 | -0.71 | -0.78 | -1.01 | -0.69 | -1 | -0.83 | -0.58 | -0.50 |
EPS (Diluted) | -1.08 | -0.73 | -0.76 | -0.76 | -0.97 | -1.05 | -0.88 | -0.96 | -0.70 | -0.81 | -1.09 | -0.99 | -1.08 | -0.75 | -0.71 | -0.78 | -1.01 | -0.69 | -1 | -0.83 | -0.58 | -0.50 |
EBITDA | -173.4M | -116.1M | -101.23M | -104.61M | -110.26M | -114.86M | -89.09M | -96.69M | -64.7M | -65.26M | -66.24M | -59.78M | -64.47M | -43.78M | -39.74M | -40.99M | -51.84M | -35.16M | -51.45M | -42.32M | -29.71M | -24.9M |
EBIT | -173.96M | -116.65M | -101.75M | -105.14M | -110.76M | -115.36M | -89.54M | -97.13M | -65.1M | -65.65M | -66.64M | -60.21M | -64.9M | -44.19M | -40.14M | -41.39M | -52.3M | -35.58M | -51.79M | -42.58M | -29.96M | -25.13M |
Depreciation & Amortization | 560K | 550K | 521K | 523K | 503K | 502K | 450K | 438K | 399K | 386K | 399K | 431K | 431K | 412K | 401K | 397K | 460K | 425K | 341K | 260K | 249K | 238K |
Add to Watchlist
Select watchlists to add or remove DYN